Mark Andreas Kluth (Mark A Kluth)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Top Venues

International journal of molecular sciences

Stem cell research & therapy

Journal of clinical medicine

JID innovations

This page only lists publications with an associated author ORCID identifier.

Publications

Berbang Meshko, Thomas L A Volatier, Johanna Mann, Mark Andreas Kluth, Christoph Ganss, Markus H Frank, Natasha Y Frank, Bruce R Ksander, Claus Cursiefen, Maria Notara
Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population. International journal of molecular sciences 25 (17) (2024)
Michael Keese, Jiaxing Zheng, Kaixuan Yan, Karen Bieback, Benito A Yard, Prama Pallavi, Christoph Reissfelder, Mark Andreas Kluth, Martin Sigl, Vugar Yugublu
Adipose-Derived Mesenchymal Stem Cells Protect Endothelial Cells from Hypoxic Injury by Suppressing Terminal UPR In Vivo and In Vitro. International journal of molecular sciences 24 (24) (2023)
Berbang Meshko, Thomas L A Volatier, Karina Hadrian, Shuya Deng, Yanhong Hou, Mark Andreas Kluth, Christoph Ganss, Markus H Frank, Natasha Y Frank, Bruce Ksander, Claus Cursiefen, Maria Notara
ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation. Cells 12 (13) (2023)
Michael Keese, Jiaxing Zheng, Kaixuan Yan, Karen Bieback, Benito A Yard, Prama Pallavi, Christoph Reissfelder, Mark Andreas Kluth, Martin Sigl, Vugar Yugublu
Adipose-Derived Mesenchymal Stem Cells Protect Endothelial Cells from Hypoxic Injury by Suppressing Terminal UPR In Vivo and In Vitro. International journal of molecular sciences 24 (24) (2023)
Elke Niebergall-Roth, Natasha Y Frank, Christoph Ganss, Markus H Frank, Mark Andreas Kluth
Skin-Derived ABCB5 + Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. International journal of molecular sciences 24 (1) (2022)
Elke Niebergall-Roth, Natasha Y Frank, Christoph Ganss, Markus H Frank, Mark Andreas Kluth
Skin-Derived ABCB5 + Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. International journal of molecular sciences 24 (1) (2022)
Elke Niebergall-Roth, Natasha Y Frank, Christoph Ganss, Markus H Frank, Mark Andreas Kluth
Skin-Derived ABCB5 + Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. International journal of molecular sciences 24 (1) (2022)
Elke Niebergall-Roth, Natasha Y Frank, Christoph Ganss, Markus H Frank, Mark Andreas Kluth
Skin-Derived ABCB5 + Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. International journal of molecular sciences 24 (1) (2022)
Andreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, Sabrina Klingele, Michael Jünger, Christoph Hasslacher, Georg Daeschlein, Lutz Stemler, Ulrich Meyer-Pannwitt, Kristin Schubert, Gerhard Klausmann, Titus Raab, Matthias Goebeler, Korinna Kraft, Jasmina Esterlechner, Hannes M Schröder, Samar Sadeghi, Seda Ballikaya, Martin Gasser, Ana M Waaga-Gasser, George F Murphy, Dennis P Orgill, Natasha Y Frank, Christoph Ganss, Karin Scharffetter-Kochanek, Markus H Frank, Mark Andreas Kluth
Translational development of ABCB5 + dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers. Stem cell research & therapy 13 (1) (2022)
Daniela Nardozi, Stefania Palumbo, Arif Ul Maula Khan, Carsten Sticht, Karen Bieback, Samar Sadeghi, Mark Andreas Kluth, Michael Keese, Norbert Gretz
Potential Therapeutic Effects of Long-Term Stem Cell Administration: Impact on the Gene Profile and Kidney Function of PKD/Mhm (Cy/+) Rats. Journal of clinical medicine 11 (9) (2022)
Elke Niebergall-Roth, Natasha Y Frank, Christoph Ganss, Markus H Frank, Mark Andreas Kluth
Skin-Derived ABCB5 + Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. International journal of molecular sciences 24 (1) (2022)
Alexandra Norrick, Jasmina Esterlechner, Elke Niebergall-Roth, Ulf Dehio, Samar Sadeghi, Hannes M Schröder, Seda Ballikaya, Nicole Stemler, Christoph Ganss, Kathrin Dieter, Ann-Kathrin Dachtler, Patrick Merz, Saadettin Sel, James Chodosh, Claus Cursiefen, Natasha Y Frank, Gerd U Auffarth, Bruce Ksander, Markus H Frank, Mark Andreas Kluth
Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency. Stem cell research & therapy 12 (1) (2021)
Julia Riedl, Michael Pickett-Leonard, Cindy Eide, Mark Andreas Kluth, Christoph Ganss, Natasha Y Frank, Markus H Frank, Christen L Ebens, Jakub Tolar
ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for recessive dystrophic epidermolysis bullosa treatment. Stem cells (Dayton, Ohio) 39 (7) (2021)
Andreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, Ann-Kathrin Dachtler, Korinna Kraft, Markus Stücker, Georg Daeschlein, Michael Jünger, Tobias Goerge, Ulrich Meyer-Pannwitt, Cornelia Erfurt-Berge, Charlotte von Engelhardt, Andreas Klare, Christiane Pfeiffer, Jasmina Esterlechner, Hannes M Schröder, Martin Gasser, Ana Maria Waaga-Gasser, Matthias Goebeler, Seda Ballikaya, Samar Sadeghi, George F Murphy, Dennis P Orgill, Natasha Y Frank, Christoph Ganss, Karin Scharffetter-Kochanek, Markus H Frank, Mark Andreas Kluth
Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial. JID innovations 2 (1) (2021)
Seda Ballikaya, Samar Sadeghi, Elke Niebergall-Roth, Laura Nimtz, Jens Frindert, Alexandra Norrick, Nicole Stemler, Nicole Bauer, Yvonne Rosche, Vanessa Kratzenberg, Julia Pieper, Tina Ficek, Markus H Frank, Christoph Ganss, Jasmina Esterlechner, Mark Andreas Kluth
Process data of allogeneic ex vivo-expanded ABCB5+ mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP. Stem cell research & therapy 11 (1) (2020)